PREVENT

There are 65 papers on PREVENT in aging research: 5 trials and 43 observational studies in people, 14 reviews. The newest story, Nov 19, 2026: “Artery stiffness linked to pollution-related heart risk in men”.

Biomarker

65 papers study it47,962 more mention it22 findings

2,530 new papers in 30 daysSee all 48,027 papers on PREVENT

“The AUC (95% CI) ranged from 0.7092 (0.7090-0.7094) to 0.7468 (0.7465-0.7471) for female and 0.6813 (0.6812-0.6814) to 0.6946 (0.6945-0.6946) for male populations.”
Independent external validation and head-to-head comparison of guideline-recommended CVD risk prediction modelsAmerican journal of preventive cardiology2026doi:10.1016/j.ajpc.2026.101625
  • Human trial5
  • Humans43
  • In silico2

Effects

3

Statin eligibility

downin humans1

1 study
  1. PREVENT is linked with lower statin eligibility in humans (Retrospective assessment using pre-STEMI clinical data; compared with PCE) (8 patients (66.7%) using PREVENT versus 11 (91.7%) using PCE).

    “Eleven patients (91.7%) met PCE-based statin eligibility criteria versus eight (66.7%) using PREVENT.”

    HumansRetrospective assessment using pre-STEMI clinical data; compared with PCEn = 12

    Could We Have Prevented STEMI? A Real-World Comparison of PREVENT and Pooled Cohort Equation Risk Assessment for Primary Prevention

    AHA Scientific Sessions 2026 abstract

Estimated 10-year cardiovascular risk

downin humans1

1 study
  1. PREVENT is linked with lower estimated 10-year cardiovascular risk in humans (Retrospective assessment using pre-STEMI clinical data; compared with PCE) (Mean estimated risk: 23.4% using PREVENT versus 27.6% using PCE).

    “Mean PCE-estimated 10-year risk was 27.6% compared with 23.4% using PREVENT.”

    HumansRetrospective assessment using pre-STEMI clinical data; compared with PCEn = 12

    Could We Have Prevented STEMI? A Real-World Comparison of PREVENT and Pooled Cohort Equation Risk Assessment for Primary Prevention

    AHA Scientific Sessions 2026 abstract

More on Estimated 10-year cardiovascular risk

10-year ASCVD risk estimates

downin humans1

1 study
  1. PREVENT is linked with lower 10-year ASCVD risk estimates in humans (Black and Latina transgender women with HIV; compared with PCE) (Risk ≥5%: PREVENT versus PCE, 9.5% versus 40.6% with male input; 9.5% versus 17.7% with female input; 8.4% versus 24.0% with female input for hormone users).

    “Use of the PREVENT calculator generates lower ASCVD risk estimates than PCE in transgender women with HIV.”

    HumansBlack and Latina transgender women with HIV; compared with PCEtransgender womensn = 108

    Cross-sectional Comparison of the PREVENT and Pooled Cohort Equations for 10-Year Atherosclerotic Cardiovascular Risk Estimates in a U.S. Cohort of Black and Latina Transgender Women with HIV

    Journal of acquired immune deficiency syndromes (1999)

More on 10-year ASCVD risk estimates

Upstream

2

Apolipoprotein B

upin humans1

1 study
  1. Apolipoprotein B is linked with better PREVENT in humans (added to PREVENT base equations) (continuous NRI 0.67, 95% CI 0.23-1.09).

    “Adding apoB to 10-year ASCVD risk estimated by the PREVENT base equations was associated with improved risk reclassification in younger adults (continuous NRI, 0.67; 95% CI, 0.23-1.09)”

    Humansadded to PREVENT base equations10-year risk

    Traditional and Emerging Lipid Markers for Cardiovascular Risk Assessment in Young vs Older Adults

    JAMA network open

More on Apolipoprotein B

Time

upin humans1

1 study
  1. time is linked with higher PREVENT in humans (no prior atherosclerotic cardiovascular disease) (β 0.28, 95% CI 0.15–0.41, p<0.001).

    “PREVENT increased (β 0.28, 95%CI:0.15-0.41, p<0.001) and LE8 scores decreased (β -0.21, 95%CI:-0.35- -0.07, p=0.002) with time.”

    Humansno prior atherosclerotic cardiovascular diseasen = 20,101

    Cardiovascular Health and Cardiovascular Disease Risk: Trends and Projections to 2040

    AHA Scientific Sessions 2025 abstract

Associations

17

Ten-year cardiovascular mortality

upin humans1

1 study
  1. PREVENT predicts ten-year cardiovascular mortality in humans (Without prior cardiovascular disease) (AUROC 0.822, 95% CI 0.79–0.85; cause-specific Cox C-index 0.838).

    “PREVENT achieved an area under the receiver operating characteristic curve of 0.822, with 95% confidence interval 0.79 to 0.85”

    HumansWithout prior cardiovascular disease10 yearsn = 5,690

    Heart risk equation outperformed machine learning in adults

    AHA Scientific Sessions 2026 abstract

ASCVD risk

downin humans1

1 study
  1. PREVENT predicts ASCVD risk in humans (ICI-treated patients; low-risk stratum) (Observed rates 6.5-fold higher than predicted in low-risk patients).

    “Both PCE and PREVENT underestimate ASCVD risk in ICI-treated patients, particularly younger patients, with event onset within 2 years.”

    HumansICI-treated patients; low-risk stratummedian follow-up 1.1 yearsn = 23,727

    Heart risk scores underestimated risk after cancer immunotherapy

    AHA Scientific Sessions 2026 abstract

Obstructive coronary artery disease

mixedin humans1

1 study
  1. PREVENT predicts obstructive coronary artery disease in humans (Patients referred for coronary computed tomography angiography without known ASCVD events) (C-statistic 0.738 (95% CI 0.719-0.756) in women versus 0.708 (95% CI 0.696-0.720) in men; p = 0.006 for the difference).

    “The C-statistics of PREVENTTM score for obstructive CAD was 0.738 (95% CI 0.719-0.756) in women and 0.708 (95% CI 0.696-0.720) in men”

    HumansPatients referred for coronary computed tomography angiography without known ASCVD eventscoronary arteryn = 17,381

    Cardiovascular Risk by the PREVENT Equation at Different Degrees of Coronary Artery Atherosclerosis Burden by Coronary Computed Tomography Angiography: A Sex-Stratified Analysis

    AHA Scientific Sessions 2026 abstract

More on Obstructive coronary artery disease

Classification below the high-risk threshold despite obstructive coronary artery disease

upin humans1

1 study
  1. PREVENT is associated with classification below the high-risk threshold despite obstructive coronary artery disease in humans (Obstructive coronary artery disease identified by coronary computed tomography angiography) (1,568 (57.5%) classified below the high-risk threshold).

    “Among these, PREVENTTM classified 1,568 (57.5%) below the high-risk threshold and 245 (8.9%) as low risk.”

    HumansObstructive coronary artery disease identified by coronary computed tomography angiographycoronary arteryn = 2,725

    Cardiovascular Risk by the PREVENT Equation at Different Degrees of Coronary Artery Atherosclerosis Burden by Coronary Computed Tomography Angiography: A Sex-Stratified Analysis

    AHA Scientific Sessions 2026 abstract

Cardiovascular risk

downin humans1

1 study
  1. PREVENT predicts cardiovascular risk in humans (postmenopausal women with and without chronic kidney disease) (Generally underpredicted risk).

    “the PREVENT model generally underpredicted risk for women with and without CKD.”

    Humanspostmenopausal women with and without chronic kidney diseasefemalesn = 21,548

    Cardiovascular Risk Prediction in Postmenopausal Women With and Without Chronic Kidney Disease: An Observational Cohort Study

    Journal of general internal medicine

Hypertension

upin humans1

1 study
  1. Hypertension is associated with PREVENT in humans (Hypertension without heart stress compared with heart stress without hypertension).

    “Group B, HT subjects without HS had significantly higher PREVENT and, interestingly, PREVENT-HF risks than group C, HS subjects without HT”

    HumansHypertension without heart stress compared with heart stress without hypertension

    Hypertension outweighs heart stress as a predictor of heart failure risk according to the prevent-hf score. EHUH2 study

    ESC Congress 2026 abstract

More on Hypertension

Reti-CVD

upin humans1

1 study
  1. Reti-CVD is associated with PREVENT in humans (hybrid care model) (κ = 0.144; weighted κ = 0.241).

    “slight to fair agreement with PREVENT (κ = 0.144; weighted κ = 0.241).”

    Humanshybrid care modeln = 1,461

    AI-powered retinal imaging for early ASCVD risk stratification in a hybrid care model: preliminary findings from SAFER

    Frontiers in artificial intelligence

More on Reti-CVD

Cardiovascular disease risk

upin humans1

1 study
  1. PREVENT predicts cardiovascular disease risk in humans (AUC 0.7092-0.7468 in females vs 0.6813-0.6946 in males).

    “The AUC (95% CI) ranged from 0.7092 (0.7090-0.7094) to 0.7468 (0.7465-0.7471) for female and 0.6813 (0.6812-0.6814) to 0.6946 (0.6945-0.6946) for male populations.”

    Humansfemales

    Independent external validation and head-to-head comparison of guideline-recommended CVD risk prediction models

    American journal of preventive cardiology

More on Cardiovascular disease risk

Cardiovascular disease risk

upin humans1

1 study
  1. PREVENT predicts cardiovascular disease risk in humans (chronic obstructive pulmonary disease) (0.76 (95% CI, 0.74, 0.77)).

    “PREVENT demonstrated the highest discrimination: 0.76 (95% CI, 0.74, 0.77)”

    Humanschronic obstructive pulmonary disease

    Performance of cardiovascular disease risk prediction tools in chronic obstructive pulmonary disease

    Annals of the American Thoracic Society

More on Cardiovascular disease risk

Exercise capacity

downin humans1

1 study
  1. Exercise capacity is associated with PREVENT in humans (beyond demographic base model) (standardized β = -0.079).

    “Double product (standardized β = 0.116), HRR at 1 min (standardized β = -0.081), and maximum METs (standardized β = -0.079) were independently associated with risk estimates.”

    Humansbeyond demographic base model56.8% malesn = 391

    Association of Treadmill Exercise Testing Parameters with PREVENT-Estimated Cardiovascular Risk: A Cross-Sectional Analysis

    Journal of clinical medicine

All 17

Latest

European Journal of Preventive Cardiology

Artery stiffness linked to pollution-related heart risk in men

In a subset of 1,015 men, artery stiffness accounted for an estimated 32% of the link between fine-particle pollution and major coronary heart disease or stroke.In a subset of 1,015 men, artery stiffness accounted for an estimated 32% of the link between fine-particle pollution and major coronary heart disease or stroke.

Cohort · 1,015 peopleMechanisms
Age and Ageing

Japan’s hip fracture reform linked to more bone drug prescribing

Prescribing for osteoporosis rose immediately by 14.7 percentage points after the reform, but no clear changes emerged in patients’ 12-month outcomes.Prescribing for osteoporosis rose immediately by 14.7 percentage points after the reform, but no clear changes emerged in patients’ 12-month outcomes.

Cohort study of 29,680 peopleIndustry & policy

See all 48,027 papers on PREVENT